[
    [
        {
            "time": "2018-01-02",
            "original_text": "Amgen (AMGN) Q4 Earnings & Sales Lag, 2018 Sales View Soft",
            "features": {
                "keywords": [
                    "Amgen",
                    "Q4",
                    "Earnings",
                    "Sales",
                    "Lag",
                    "Soft"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Amgen (AMGN) Q4 Earnings & Sales Lag, 2018 Sales View Soft",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-02-01",
            "original_text": "5 Top Earnings Growth Stocks to Buy in February",
            "features": {
                "keywords": [
                    "Top",
                    "Earnings",
                    "Growth",
                    "Stocks",
                    "Buy",
                    "February"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "5 Top Earnings Growth Stocks to Buy in February",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-02-08",
            "original_text": "AstraZeneca (AZN) Beats on Q4 Earnings, Guides for 2018",
            "features": {
                "keywords": [
                    "AstraZeneca",
                    "Q4",
                    "Earnings",
                    "Beats",
                    "Guides",
                    "2018"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "AstraZeneca (AZN) Beats on Q4 Earnings, Guides for 2018",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-01-25",
            "original_text": "Gilead's (GILD) HCV Segment to Decline Further in Q4 Earnings?",
            "features": {
                "keywords": [
                    "Gilead",
                    "HCV",
                    "Segment",
                    "Decline",
                    "Q4",
                    "Earnings"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "biotechnology"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Gilead's (GILD) HCV Segment to Decline Further in Q4 Earnings?",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-01-15",
            "original_text": "The Best Dividend Reinvestment Plans For 2018",
            "features": {
                "keywords": [
                    "Best",
                    "Dividend",
                    "Reinvestment",
                    "Plans",
                    "2018"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "The Best Dividend Reinvestment Plans For 2018",
                "Correlation": 3,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-02-10",
            "original_text": "Look Beyond Pharma to Invest in Marijuana Industry",
            "features": {
                "keywords": [
                    "Pharma",
                    "Invest",
                    "Marijuana",
                    "Industry"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "marijuana"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "Look Beyond Pharma to Invest in Marijuana Industry",
                "Correlation": 4,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-02-12",
            "original_text": "3 Top Biotherapeutics Stocks to Buy Now",
            "features": {
                "keywords": [
                    "Biotherapeutics",
                    "Stocks",
                    "Buy",
                    "Now"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "biotechnology"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "3 Top Biotherapeutics Stocks to Buy Now",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]